Endocrinology, Vol 119, 580-585, Copyright © 1986 by Endocrine Society

ARTICLES

Thyroid hormone regulation of epidermal growth factor receptor levels in mouse mammary glands

BK Vonderhaar, E Tang, RR Lyster and MC Nascimento

The specific binding of iodinated epidermal growth factor ([125I]iodo- EGF) to membranes prepared from the mammary glands and spontaneous breast tumors of euthyroid and hypothyroid mice was measured in order to determine whether thyroid hormones regulate the EGF receptor levels in vivo. Membranes from hypothyroid mammary glands of mice at various developmental ages bound 50-65% less EGF than those of age-matched euthyroid controls. Treatment of hypothyroid mice with L-T4 before killing restored binding to the euthyroid control level. Spontaneous breast tumors arising in hypothyroid mice also bound 30-40% less EGF than tumors from euthyroid animals even after in vitro desaturation of the membranes of endogenous growth factors with 3 M MgCl2 treatment. The decrease in binding in hypothyroid membranes was due to a decrease in the number of binding sites, not to a change in affinity of the growth factor for its receptor, as determined by Scatchard analysis of the binding data. Both euthyroid and hypothyroid membranes bound EGF primarily to a single class of high affinity sites [dissociation constant (Kd) = 0.7-1.8 nM]. Euthyroid membranes bound 28.4 +/- (SE) 0.6 fmol/mg protein, whereas hypothyroid membranes bound 15.5 +/- 1.0 fmol/mg protein. These data indicate that EGF receptor levels in normal mammary glands and spontaneous breast tumors in mice are subject to regulation by thyroid status.

This article has been cited by other articles:

				A. Altieri, A. Tavani, S. Gallus, C. Bosetti, R. Talamini, S. Franceschi, F. Levi, C. La Vecchia, M. S. Simon, and M.-T. C. Tang Correspondence re: Simon et al., Do Thyroid Disorders Increase the Risk of Breast Cancer? 11: 1574-1578, 2002 Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 684 - 686. [Full Text] [PDF]